Nicholas Curtis - LENSAR CEO President
| LNSR Stock | USD 7.53 0.16 2.08% |
CEO
Nicholas Curtis is CEO President of LENSAR Inc
| Age | 68 |
| Address | 2800 Discovery Drive, Orlando, FL, United States, 32826 |
| Phone | 888 536 7271 |
| Web | https://www.lensar.com |
Nicholas Curtis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Nicholas Curtis against LENSAR stock is an integral part of due diligence when investing in LENSAR. Nicholas Curtis insider activity provides valuable insight into whether LENSAR is net buyers or sellers over its current business cycle. Note, LENSAR insiders must abide by specific rules, including filing SEC forms every time they buy or sell LENSAR'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Nicholas Curtis over six months ago Acquisition by Nicholas Curtis of 71400 shares of LENSAR subject to Rule 16b-3 |
LENSAR Management Efficiency
The company has return on total asset (ROA) of (0.0938) % which means that it has lost $0.0938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3838) %, meaning that it created substantial loss on money invested by shareholders. LENSAR's management efficiency ratios could be used to measure how well LENSAR manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/30/2024, Return On Tangible Assets is likely to drop to -0.26. In addition to that, Return On Capital Employed is likely to drop to -0.22. At this time, LENSAR's Net Tangible Assets are relatively stable compared to the past year. As of 11/30/2024, Non Currrent Assets Other is likely to grow to about 2.2 M, while Total Current Assets are likely to drop slightly above 38.9 M.Similar Executives
| Found 10 records | CEO Age | ||
| Ronald MD | Rxsight | 61 | |
| Michael Stewart | STRATA Skin Sciences | 67 | |
| Steven Williamson | Pulmonx Corp | 51 | |
| Karen Zaderej | Axogen Inc | 62 | |
| Gary Maharaj | SurModics | 61 | |
| Massimo Calafiore | Orthofix Medical | 52 | |
| Glendon French | Pulmonx Corp | 62 | |
| Dolev Rafaeli | STRATA Skin Sciences | 60 | |
| David Bruce | IRIDEX | 65 | |
| Joel Becker | Neuropace | 56 | |
Management Performance
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.0938 |
LENSAR Inc Leadership Team
Elected by the shareholders, the LENSAR's board of directors comprises two types of representatives: LENSAR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LENSAR. The board's role is to monitor LENSAR's management team and ensure that shareholders' interests are well served. LENSAR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LENSAR's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA II, CFO Secretary | ||
| Nicholas Curtis, CEO President | ||
| Alan Connaughton, Chief Officer | ||
| Kendra Wong, Principal Officer |
LENSAR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LENSAR a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.0938 | ||||
| Profit Margin | (0.34) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 71.27 M | ||||
| Shares Outstanding | 11.61 M | ||||
| Shares Owned By Insiders | 19.57 % | ||||
| Shares Owned By Institutions | 42.40 % | ||||
| Number Of Shares Shorted | 43.68 K | ||||
| Price To Book | 3.85 X |
Pair Trading with LENSAR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LENSAR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will appreciate offsetting losses from the drop in the long position's value.Moving together with LENSAR Stock
Moving against LENSAR Stock
| 0.92 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.76 | VERO | Venus Concept | PairCorr |
| 0.56 | CI | Cigna Corp | PairCorr |
| 0.48 | DRIO | DarioHealth Corp | PairCorr |
The ability to find closely correlated positions to LENSAR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LENSAR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LENSAR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LENSAR Inc to buy it.
The correlation of LENSAR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LENSAR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LENSAR Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LENSAR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for LENSAR Stock Analysis
When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.